MedTrace Logo

Web-Delivered Acceptance & Commitment Therapy for Smokers With Bipolar Disorder

NCT02750904 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 51

Last updated 2019-10-14

No results posted yet for this study

Summary

This purpose of the study is to develop and test a new website to help people who have bipolar disorder quit smoking.

Conditions

Interventions

BEHAVIORAL

Experimental plus Nicotine Replacement Therapy

Behavioral: Experimental plus Nicotine Replacement Therapy will be built to specifically address challenges of smoking cessation for individuals with bipolar disorder. Includes four in person and four phone visits. Therapy information is withheld to protect the integrity of the study.

BEHAVIORAL

Control plus Nicotine Replacement Therapy

Includes four in-person and four phone visits

Sponsors & Collaborators

  • Palo Alto Veterans Institute for Research

    collaborator OTHER

  • Bedford Research Corporation, Inc.

    collaborator OTHER

  • Jefferson Center, Community Mental Health Clinic

    collaborator UNKNOWN

  • VA Central Western Massachusetts Healthcare System

    collaborator UNKNOWN

  • Fred Hutchinson Cancer Center

    lead OTHER

Principal Investigators

  • Jaimee Heffner, Ph.D. · Fred Hutchinson Cancer Research Institute

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-04-03
Primary Completion
2019-05-14
Completion
2019-05-14

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02750904 on ClinicalTrials.gov